Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Clinical trial NCT00085930 · COMPLETED
Trial details
- NCT number
- NCT00085930
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2010-01-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.